Patent classifications
C08J2207/10
HIGH STRENGTH BIOMEDICAL MATERIALS
High strength biomedical materials and processes for making the same are disclosed. Included in the disclosure are nanoporous hydrophilic solids that can be extruded with a high aspect ratio to make high strength medical catheters and other devices with lubricious and biocompatible surfaces.
POLYMER AEROGEL WITH IMPROVED MECHANICAL AND THERMAL PROPERTIES
An aerogel that includes an open-cell structured polymer matrix is disclosed. The aerogel includes 5 wt. % to 50 wt. % of a polyamic amide polymer, based on the total weight of the aerogel, pores and at least 90% of the pore volume of the aerogel is made up of macropores, a porosity of at least 50%, as measure according to ASTM D4404-10, a density of 0.01 g/cm.sup.3 to 0.5 g/cm.sup.3, and the aerogel is thermally stable to resist browning at 330° C.
POLYMER AEROGEL WITH IMPROVED MECHANICAL AND THERMAL PROPERTIES
Aerogel compositions that include polyamic amides, methods for preparing the aerogel compositions, and articles of manufacture that include or manufactured from the aerogel compositions are described.
POLYMER GEL AND PREPARATION METHOD THEREFOR
When a polymer gel has excellent mechanical strength and an ability to maintain surface wetness for a longer time, the polymer gel may be very widely applied to a variety of fields. The present disclosure provides example embodiments of a polymer gel having excellent mechanical strength and an ability to maintain surface wetness for a longer time. Further, the present disclosure provides example embodiments of a method of preparing the polymer gel.
POLYMER MATERIALS
Polyurethane material for indicating pH at a locus, preferably as indication of presence of microbes, comprising a polyurethane network having immobilised therein one or more hydrophilic copolymers, the or each said copolymer comprising:
hydrophilic monomer; and
indicating monomer, which provides an indication in response to a change in hydrophilic state of said hydrophilic monomer and/or copolymer;
characterised in that the or each copolymer further comprises one or a plurality of ionisable groups or moieties or polymerisable monomers having one or more characteristic pKa values in the range 5 to 10 and which are responsive to pH at the locus in the range pH 5 to pH 10
and in that hydrophilic state of hydrophilic copolymer is dependent on ionisation of said ionisable groups, moieties or monomers; kit and device comprising the material and process for preparation thereof; and use in detecting or sensing microbes or pH.
METHODS OF USING POLYMERS
Provided herein are materials and methods of reducing contamination in a biological substance or treating contamination in a subject by one or more toxins comprising contacting the biological substance with an effective amount of a sorbent capable of sorbing the toxin, wherein the sorbent comprises a plurality of pores ranging from 50 Å to 40,000 Å with a pore volume of 0.5 cc/g to 5.0 cc/g and a size of 0.05 mm to 2 cm and sorbing the toxin. Also provided are kits to reduce contamination by one or more toxins in a biological substance comprising a sorbent capable of sorbing a toxin, wherein the sorbent comprises a plurality of pores ranging from 50 Å to 40,000 Å with a pore volume of 0.5 cc/g to 5.0 cc/g and a size of 0.05 mm to 2 cm and a vessel to store said sorbent when not in use together with packaging for same.
SILICONE FOAM COMPOSITIONS RAPIDLY CROSS-LINKABLE AT AMBIENT TEMPERATURES AND METHODS OF MAKING AND USING SAME
Provided are rapidly cross-linkable silicone foam compositions, kits, and methods for filling implanted medical devices in situ or in vivo, the implanted medical devices, including for example, body implants and tissue expanders, the compositions including a platinum divinyl disiloxane complex; a low viscosity vinyl terminated polydimethylsiloxane; a low viscosity hydride terminated polydimethylsiloxane; a silicone cross-linker; and a gas and/or gas-filled microcapsules, where the rapidly cross-linkable silicone foam composition has a viscosity of ≤150 cPs for ≥1 min. post-preparation and ≤300 cPs≤5 min. post-preparation, at ambient temperature.
SKIN-CONTACT PRODUCT HAVING MOISTURE AND MICROCLIMATE CONTROL
Skin-contact products with a transpiration function such as medical devices or medicinal products, of which face masks, aspirators, ventilators, breast pumps or wound dressings are examples are described especially a skin-contact product with a transpiration function with an improved microclimate at a patient interface material-skin contact area. In an embodiment a material system is described that comprises a hydrophobic silicone base material and a hydrophilic silicone material that is combined with the hydrophobic base material.
Polymer aerogel with improved mechanical and thermal properties
An aerogel that includes an open-cell structured polymer matrix that can have 5 wt. % to 50 wt. % of a polyamic amide polymer, based on the total weight of the aerogel is disclosed. The aerogel can have a density of 0.05 g/cm.sup.3 to 0.35 g/cm.sup.3 and can be thermally stable to resist browning at 330° C.
DEGRADABLE HEMOSTATIC SPONGE AND PREPARATION METHOD AND USE THEREOF, AND DEGRADABLE DRUG-LOADED HEMOSTATIC SPONGE
The present disclosure belongs to the technical field of hemostatic materials, and specifically relates to a degradable hemostatic sponge and a preparation method and use thereof, and a degradable drug-loaded hemostatic sponge. The degradable hemostatic sponge provided by the present disclosure is prepared from raw materials including a crosslinking-modified starch and a cellulose through freeze-drying, where a mass ratio of the crosslinking-modified starch to the cellulose is (0.2-5):1. The degradable hemostatic sponge provided by the present disclosure has a high water-absorbing rate and a large water-absorbing capacity, shows a high support strength and a long support time after water absorption, and is made from plant-derived raw materials and thus may be completely biodegraded. The degradable drug-loaded starch hemostatic sponge provided by the present disclosure has a drug-loaded coating attached to a surface of the sponge, where the drug is slowly released while a support is maintained.